Business Description
Novo Integrated Sciences Inc
NAICS : 621999
SIC : 8361
ISIN : US67011T1025
Description
Novo Integrated Sciences Inc is a medical care company. It provides specialized physiotherapy, chiropractic care, occupational therapy, eldercare, laser therapeutics, massage therapy, acupuncture, neurological functions, kinesiology, and others. It has two reportable segments: healthcare services which generates majority of the revenue, and product sales.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.34 | |||||
| Equity-to-Asset | 0.28 | |||||
| Debt-to-Equity | 0.45 | |||||
| Debt-to-EBITDA | -0.28 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -5.36 | |||||
| Beneish M-Score | 8.84 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -28.7 | |||||
| 3-Year EBITDA Growth Rate | 26.4 | |||||
| 3-Year EPS without NRI Growth Rate | 12.9 | |||||
| 3-Year FCF Growth Rate | -4.5 | |||||
| 3-Year Book Growth Rate | -50 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 44.1 | |||||
| 9-Day RSI | 39.89 | |||||
| 14-Day RSI | 35.37 | |||||
| 3-1 Month Momentum % | -88.12 | |||||
| 6-1 Month Momentum % | -96.46 | |||||
| 12-1 Month Momentum % | -96.94 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.27 | |||||
| Quick Ratio | 0.22 | |||||
| Cash Ratio | 0.07 | |||||
| Days Inventory | 46.59 | |||||
| Days Sales Outstanding | 75.61 | |||||
| Days Payable | 128.97 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -88.7 | |||||
| Shareholder Yield % | 391.58 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 37.68 | |||||
| Operating Margin % | -77.47 | |||||
| Net Margin % | -179.98 | |||||
| FCF Margin % | -35.16 | |||||
| ROE % | -113.56 | |||||
| ROA % | -68.02 | |||||
| ROIC % | -28.03 | |||||
| 3-Year ROIIC % | -258.06 | |||||
| ROC (Joel Greenblatt) % | -245.38 | |||||
| ROCE % | -75.51 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.04 | |||||
| PB Ratio | 0.08 | |||||
| EV-to-EBIT | -0.2 | |||||
| EV-to-EBITDA | -0.23 | |||||
| EV-to-Revenue | 0.28 | |||||
| EV-to-FCF | -0.8 | |||||
| Price-to-GF-Value | 0.06 | |||||
| Earnings Yield (Greenblatt) % | -500 | |||||
| FCF Yield % | -581.05 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:NVOS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Novo Integrated Sciences Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 13.517 | ||
| EPS (TTM) ($) | -1.31 | ||
| Beta | -1.95 | ||
| 3-Year Sharpe Ratio | -0.74 | ||
| 3-Year Sortino Ratio | -1.01 | ||
| Volatility % | 127.62 | ||
| 14-Day RSI | 35.37 | ||
| 14-Day ATR ($) | 0.017337 | ||
| 20-Day SMA ($) | 0.047448 | ||
| 12-1 Month Momentum % | -96.94 | ||
| 52-Week Range ($) | 0.027 - 1.4099 | ||
| Shares Outstanding (Mil) | 19.05 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Novo Integrated Sciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Novo Integrated Sciences Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Novo Integrated Sciences Inc Frequently Asked Questions
What is Novo Integrated Sciences Inc(NVOS)'s stock price today?
The current price of NVOS is $0.04. The 52 week high of NVOS is $1.41 and 52 week low is $0.03.
When is next earnings date of Novo Integrated Sciences Inc(NVOS)?
The next earnings date of Novo Integrated Sciences Inc(NVOS) is 2025-01-22 Est..
Does Novo Integrated Sciences Inc(NVOS) pay dividends? If so, how much?
Novo Integrated Sciences Inc(NVOS) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers